Longitudinal Follow-Up of Gross Motor Function in Children with Congenital Zika Virus Syndrome from a Cohort in Rio de Janeiro, Brazil.
congenital zika virus syndrome
motor development
zika virus
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
28 05 2022
28 05 2022
Historique:
received:
20
04
2022
revised:
25
05
2022
accepted:
27
05
2022
entrez:
24
6
2022
pubmed:
25
6
2022
medline:
28
6
2022
Statut:
epublish
Résumé
Knowledge of how congenital Zika syndrome (CZS) impacts motor development of children longitudinally is important to guide management. The objective of the present study was to describe the evolution of gross motor function in children with CZS in a Rio de Janeiro hospital. In children with CZS without arthrogryposis or other congenital osteoarticular malformations who were followed in a prospective cohort study, motor performance was evaluated at two timepoints using the Gross Motor Function Classification System (GMFCS) and the Gross Motor Function Measurement test (GMFM-88). Among 74 children, at the baseline evaluation, the median age was 13 (8-24) months, and on follow-up, 28 (24-48) months. According to GMFCS at the second timepoint, 6 children were classified as mild, 11 as moderate, and 57 as severe. In the GMFM-88 assessment, children in the severe group had a median score of 10.05 in the baseline evaluation and a follow-up score of 12.40, the moderate group had median scores of 25.60 and 29.60, and the mild group had median scores of 82.60 and 91.00, respectively. Although a small developmental improvement was observed, the motor impairment of children was mainly consistent with severe cerebral palsy. Baseline motor function assessments were predictive of prognosis.
Identifiants
pubmed: 35746646
pii: v14061173
doi: 10.3390/v14061173
pmc: PMC9229488
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIAID NIH HHS
ID : RO1/ AI140718
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI140718
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 205377/Z/16/Z
Pays : United Kingdom
Références
Radiology. 2017 Dec;285(3):744-761
pubmed: 29155634
PLoS One. 2018 Jul 26;13(7):e0201495
pubmed: 30048541
Eur J Pediatr. 2022 Feb;181(2):783-788
pubmed: 34596742
Childs Nerv Syst. 2018 Jan;34(1):63-71
pubmed: 29110197
JAMA Pediatr. 2017 Mar 1;171(3):288-295
pubmed: 27812690
J Dev Behav Pediatr. 2020 Feb/Mar;41(2):134-140
pubmed: 31453893
J Child Neurol. 2019 Feb;34(2):81-85
pubmed: 30421639
PLoS One. 2020 Feb 28;15(2):e0229434
pubmed: 32109947
BJOG. 2013 Sep;120 Suppl 2:9-26, v
pubmed: 23678873
N Engl J Med. 2018 Dec 13;379(24):2377-2379
pubmed: 30575464
J Child Neurol. 2020 Mar;35(3):202-207
pubmed: 31718421
AJNR Am J Neuroradiol. 2017 Jul;38(7):1427-1434
pubmed: 28522665
JAMA Netw Open. 2019 Jul 3;2(7):e198124
pubmed: 31365112
Epilepsia. 2020 Mar;61(3):509-518
pubmed: 32065676
Dev Med Child Neurol. 2020 Feb;62(2):221-226
pubmed: 30945276
Nat Med. 2019 Aug;25(8):1213-1217
pubmed: 31285631
Dysphagia. 2021 Aug;36(4):583-594
pubmed: 32886254
Lancet. 2016 Aug 27;388(10047):891-7
pubmed: 27372398
Childs Nerv Syst. 2018 Jan;34(1):73-78
pubmed: 29127595
MMWR Morb Mortal Wkly Rep. 2016 Dec 02;65(47):1343-1348
pubmed: 27906905
Dev Med Child Neurol. 2000 May;42(5):292-6
pubmed: 10855648
Lancet Infect Dis. 2018 Mar;18(3):328-336
pubmed: 29242091
JAMA. 2002 Sep 18;288(11):1357-63
pubmed: 12234229
Infant Behav Dev. 2017 Nov;49:70-82
pubmed: 28755567
Int J Environ Res Public Health. 2018 May 29;15(6):
pubmed: 29844290
Int J Infect Dis. 2021 Apr;105:399-408
pubmed: 33610784
BMC Pediatr. 2020 Oct 10;20(1):472
pubmed: 33038931